sponsored by IBM Line of Business
Posted:  22 Feb 2008
Published:  01 Jan 2006
Format:  PDF
Length:  20  Page(s)
Type:  White Paper
Language:  English
ABSTRACT:
While the pharmaceutical industry is seeking to replace the blockbuster model of drug development, healthcare is struggling with rapidly rising costs. This paper explores how by collaborating and sharing data, the two industries can realize the full value of the information they collect--and improve patient treatments.



Authors

Heather Fraser
Global Leader for the Life Sciences/Pharmaceuticals Team ,  IBM
Heather Fraser is a pharmacist with over 20 years of industry experience and has held positions within R&D, consultancy and community pharmacy. She is currently the global leader for the Life Sciences/ Pharmaceuticals team at the IBM Institute for Business Value. Heather has published a variety of articles on pharmaceutical industry issues in publications such as Pharmaceutical Technology, GCP Journal, PharmaFocus Asia, Biopartnering Today and Drug Discovery and Development.

Ed Mounib
Senior Consultant ,  IBM
Ed Mounib is a senior consultant in the IBM Institute for Business Value’s Healthcare team. In this role, he develops and presents original, analytically-driven thought leadership and techniques to enable clients to realize business value. Prior to joining IBM, Ed held various posts in the healthcare and pharmaceutical industries, including corporate strategy, product planning, market intelligence and marketing. Ed has an MBA and Master of Public Health in epidemiology, as well as a first degree in biology.

Sarah Payne
Leader of the Value Infusion: Life Sciences/Pharmaceuticals Team ,  IBM
Sarah Payne worked in the pharmaceutical industry for 20 years before becoming a consultant. Her primary expertise lies in clinical development strategy, performance management and process improvement. She has also acted as a subject matter expert on health economics and health policy. Sarah has published widely on respiratory medicine and health economics, spoken at various conferences, trained government reimbursement agencies and lectured on health outcomes at St. Bartholomew’s Hospital, London. Sarah’s qualifications include an MSc in health economics and an MBA. She is currently the leader of the Value Infusion: Life Sciences/ Pharmaceuticals team at the IBM Institute for Business.



BROWSE RELATED RESOURCES
Convergence | Data Management | Globalization | Health Care Industry | HIPAA | Interoperability | Pharmaceutical Industry

View All Resources sponsored by IBM Line of Business

About TechTarget:

TechTarget provides enterprise IT professionals with the information they need to perform their jobs - from developing strategy, to making cost-effective IT purchase decisions and managing their organizations' IT projects - with its network of technology-specific Web sites, events and magazines

All Rights Reserved, Copyright 2000 - 2014, TechTarget | Read our Privacy Statement